Diabetes navigator to boost continuous glucose monitor use in people with type 1 diabetes
Implementation of a diabetes navIgator to Mitigate disPArities and improve CGM upTake and sustained use across the lifespan of T1D (IMPACT T1D)
This project offers a diabetes navigator program to help people with type 1 diabetes start and keep using continuous glucose monitors across childhood, adolescence, and adulthood.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Johns Hopkins University NIH-funded |
| Lab location | 1 site (Baltimore, United States) |
| Project ID | NIH-11160484 on NIH RePORTER |
What this research studies
You would be offered a diabetes navigator who helps you try a continuous glucose monitor (CGM) at the point of care, provides standardized education, and gives ongoing support to address personal and system barriers to use. The program is being implemented across pediatric, emerging adult, and adult clinics with a focus on underserved and minority communities where CGM use is low. The team builds on a pilot that provided trial CGMs and education and will follow participants in real-world clinic settings to make the approach feasible and sustainable. They will track who adopts and continues using CGMs and identify barriers at the patient, provider, and system levels.
Who could benefit from this research
Good fit: People with type 1 diabetes of any age—children, adolescents, emerging adults, and adults—especially those from underserved or minority communities who are not currently using a CGM.
Not a fit: People without type 1 diabetes, and those who already use and are happy with a CGM, are unlikely to gain benefit from this program.
Why it matters
Potential benefit: If successful, this program could increase CGM uptake and sustained use, which may improve blood sugar control and reduce diabetes-related disparities.
How similar studies have performed: A pilot at the same institution showed that offering a trial CGM with standardized education at the point of care increased initial CGM uptake, but maintaining long-term personal use remains unproven.
Where this research is happening
Baltimore, United States
- Johns Hopkins University — Baltimore, United States (Active)
Researchers
- Principal investigator: Wolf, Risa Michelle — Johns Hopkins University
- Study coordinator: Wolf, Risa Michelle
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.